Pharmaceuticals and the Internet Drug Regulatory Authorities' Perspective - Joint NLN-WHI Workshop, 24-25 September 2001
(2002; 80 pages) Voir le document au format PDF
Table des matières
Afficher le documentExecutive Summary
Afficher le documentOverview of activities by the World Health Organization - Dr Lembit Rägo
Afficher le documentOverview of activities by the Nordic Council on Medicines - Dr Ola Westbye
Fermer ce répertoireCountry Experiences
Afficher le documentSweden: Publication bias of clinical trials - Dr Juliette Säwe
Afficher le documentThe Netherlands: Pharmaceuticals and e-commerce - Dr Hans Heuvelmans
Afficher le documentDenmark: Web site of the Institute for Rational Pharmacotherapy - Ms Karin Friis Bach
Afficher le documentDenmark: Danish Medicines Agency web site - Mr Karsten Jørgensen
Afficher le documentSouth Africa: The South African perspective on medicine regulation - Dr Wilbert Bannenberg
Afficher le documentTunisia - Dr Amor Toumi
Afficher le documentEstonia - Dr Main Uusküla
Afficher le documentBulgaria: Bulgarian Drug Agency - Rozalina Asenova Kulaksazova
Afficher le documentThe Danish Consumer Council - Ms Margrethe Nielsen
Afficher le documentSwedish Industry Association - Dr Håkan Mandahl
Afficher le documentIntroduction to discussion points - Dr Lembit Rägo
Afficher le documentQuality aspects - Dr Ola Westbye
Afficher le documentPilot study on drug regulatory web sites: Current status and future challenges - Ms Elodie Jambert
Afficher le documentThe WHO model web site for drug regulatory authorities - Dr Lembit Rägo, Ms Elodie Jambert, Mr Jorg Hetzke
Afficher le documentConcluding discussion
Ouvrir ce répertoire et afficher son contenuAnnexes
Afficher le documentReferences
Afficher le documentBack cover
 

Denmark: Danish Medicines Agency web site - Mr Karsten Jørgensen

Mr Karsten Jørgensen
Danish Medicines Agency, Denmark

This presentation covers both the Danish Medicines Agency web site (www.dkma.dk), which is in English and Danish, and the web site of the European Agency for the Evaluation of Medicinal Products (EMEA) (http://www.emea.eu.int/).

On the Danish Medicines Agency web site, there is information about the Agency, medicinal products, pharmaceutical companies (an application form for pharmaceutical companies to register products, fees and payment), reimbursement, pharmacy and non-prescription products (pharmacy licensing, pharmacy reimbursement, distributors), e-commerce (medicinal products and customs regulations), extensive statistical information (statistics on medicinal products, a price index for medicinal products, consumption analyses), and medical devices. There is also an explanation of how to handle e-business (with a short introduction) and active feedback where visitors can ask questions, e.g., whether buying a certain medicine through the web is legal. All Legal Acts are on one web page.

“If you want people to comply with your regulations, you have to make them readily available.”

Discussion and comments

Is the daily defined dose (DDD) related to price? Yes.

What is the target audience of the web site? The primary targets are companies and the public; it is less oriented toward doctors and pharmacists.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 19 janvier 2012